Griffith

109 (no PLGF) and R2  = 0.06 (PLGF). Two-sample Kolmogorov-Smirnov’s test reveals a p -value of 0.44. Overall, addition of PLGF improves DRs of 3.3% for 1% FPR, 1.7% for 3% FPR, and 1.4% for 5% FPR, respectively. Conclusion  Addition of PLGF to prenatal screening using serum analytes mildly improves trisomy 21 DRs as a function of FPRs.…[Read more]

All the authors agreed that the article should be retracted. The Editor apologizes to the readership for any inconvenience caused. [the original article was published in International Journal of Oncology 50 1821‑1831, 2017; DOI 10.3892/ijo.2017.3943].Long non‑coding RNAs (lncRNAs) have emerged as key players in the development and progression of…[Read more]

Besides the well-known use in supporting the non-invasive diagnosis of non-tumoral dermatoses (general dermatology), dermoscopy has been shown to be a promising tool also in predicting and monitoring therapeutic outcomes of such conditions, with the consequent improvement/optimization of their treatment. In the present paper, we sought to provide…[Read more]

MTT assay demonstrated that GaCl-Pc did not have toxicity towards a neuronal cell line (A1) in culture rather, showed protective effects on Aβ-induced toxicity. Moreover, it dosedependently decreased Aβ-induced reactive oxygen species levels in A1 culture.

Thus, our result demonstrated that GaCl-Pc decreased Aβ aggregation and de…[Read more]

222; 95% confidence interval (CI), 1.100-1.357]. Stratified analysis revealed that at localized tumor stage and at regional tumor stage or among white patients, any Medicaid insurance was an independent predictor of an unfavorable survival outcome.

Among the RCC patients in this study, individuals with insurance experienced improved CSS…[Read more]